ABSTRACT
I. Background Lung transplantation is now an established therapy for end-stage pulmonary disease; survival and post-transplantation quality of life continue to improve. With slightly more than 2000 transplants performed globally in each of the last few years, there has been continued increase in the number of lung transplants performed over the last decade (1). The one-year survival rate now approaches 80%, with a 63% three-year, 51% five-year, and 28% ten-year survival rate Scientific Registry of Transplant Recipients (SRTR). The trend during this time as been for recipients to be older, especially in the United States.
